AI assistant
TruScreen Group Limited — AGM Information 2018
Sep 27, 2018
66285_rns_2018-09-27_2e1cf972-825c-4742-b090-e8cf0aee075e.pdf
AGM Information
Open in viewerOpens in your device viewer
NZX and Media Release 27 September 2017
NZX Limited
WELLINGTON
TruScreen Annual Meeting
Chairman’s Presentation
TruScreen Limited (NZAX: TRU), advises that its Annual Meeting will be held at Link Market Services, Level 11, Deloitte Centre, 80 Queen Street Auckland, 1010, at 2.00pm today.
Please find attached a copy of the Chairman’s presentation to shareholders.
For more information visit www.truscreen.com
Contact
Martin Dillon
TruScreen Chief Executive Officer
Email: [email protected]
-ENDS-
About TruScreen:
TruScreen’s real time cervical cancer technology utilises a digital wand which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissue. A sophisticated proprietary algorithm framework distinguishes between normal and abnormal (cancerous and precancerous) tissue to identify precancerous change, or cervical intraepithelial neoplasia (CIN). A Single Use Sensor (SUS) is used for each patient to protect against cross-infection.
==> picture [286 x 179] intentionally omitted <==